These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22131028)

  • 1. Integrin-targeted stabilized nanoparticles for an efficient delivery of siRNAs in vitro and in vivo.
    Srinivasan C; Peer D; Shimaoka M
    Methods Mol Biol; 2012; 820():105-16. PubMed ID: 22131028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrin-targeted nanoparticles for siRNA delivery.
    Ben-Arie N; Kedmi R; Peer D
    Methods Mol Biol; 2012; 757():497-507. PubMed ID: 21909930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming RNAi transduction in leukocytes using targeted and stabilized nanoparticles.
    Elfakess R; Peer D
    IDrugs; 2010 Sep; 13(9):626-31. PubMed ID: 20799145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring cell type-specific internalizing antibodies for targeted delivery of siRNA.
    Liu B
    Brief Funct Genomic Proteomic; 2007 Jun; 6(2):112-9. PubMed ID: 17670766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-mediated delivery of siRNAs for anti-HIV therapy.
    Kim SS; Subramanya S; Peer D; Shimaoka M; Shankar P
    Methods Mol Biol; 2011; 721():339-53. PubMed ID: 21431696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrodynamic delivery protocols.
    Rychahou PG; Evers BM
    Methods Mol Biol; 2010; 623():189-95. PubMed ID: 20217552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. siRNAs with guts.
    Maclachlan I
    Nat Biotechnol; 2008 Apr; 26(4):403-5. PubMed ID: 18392024
    [No Abstract]   [Full Text] [Related]  

  • 8. A review of nanocarriers for the delivery of small interfering RNA.
    Kesharwani P; Gajbhiye V; Jain NK
    Biomaterials; 2012 Oct; 33(29):7138-50. PubMed ID: 22796160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immobilized nanoparticle-based platform for efficient gene knockdown of targeted cells in the circulation.
    Huang Z; King MR
    Gene Ther; 2009 Oct; 16(10):1271-82. PubMed ID: 19554031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
    Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
    Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA.
    Sabbioni S; Callegari E; Manservigi M; Argnani R; Corallini A; Negrini M; Manservigi R
    Gene Ther; 2007 Mar; 14(5):459-64. PubMed ID: 17051250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. siRNA stabilization prolongs gene knockdown in primary T lymphocytes.
    Mantei A; Rutz S; Janke M; Kirchhoff D; Jung U; Patzel V; Vogel U; Rudel T; Andreou I; Weber M; Scheffold A
    Eur J Immunol; 2008 Sep; 38(9):2616-25. PubMed ID: 18792414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4.
    Zhou N; Fang J; Mukhtar M; Acheampong E; Pomerantz RJ
    Gene Ther; 2004 Dec; 11(23):1703-12. PubMed ID: 15306840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient and targeted delivery of siRNA in vivo.
    Shim MS; Kwon YJ
    FEBS J; 2010 Dec; 277(23):4814-27. PubMed ID: 21078116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNAi using a chitosan/siRNA nanoparticle system: in vitro and in vivo applications.
    Andersen MØ; Howard KA; Kjems J
    Methods Mol Biol; 2009; 555():77-86. PubMed ID: 19495689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.
    Reich SJ; Fosnot J; Kuroki A; Tang W; Yang X; Maguire AM; Bennett J; Tolentino MJ
    Mol Vis; 2003 May; 9():210-6. PubMed ID: 12789138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonviral in vivo delivery of therapeutic small interfering RNAs.
    Aigner A
    Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient siRNA delivery to mammalian cells using layered double hydroxide nanoparticles.
    Ladewig K; Niebert M; Xu ZP; Gray PP; Lu GQ
    Biomaterials; 2010 Mar; 31(7):1821-9. PubMed ID: 19922997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convenient targeting of stealth siRNA-lipoplexes to cells with chelator lipid-anchored molecules.
    Herringson TP; Altin JG
    J Control Release; 2009 Nov; 139(3):229-38. PubMed ID: 19595724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L; Charnet A; Morris MC; Aldrian-Herrada G; Heitz F; Divita G
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):44-6. PubMed ID: 17233597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.